SCHEMBL19080098

SCHEMBL19080098

c1ccc2cc(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7cc8c(cc7c6)oc6cc7ccccc7cc68)ccc5c4)c4ccccc34)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.42
ESR2 Q92731 3/20 0.42
ALOX5 P09917 2/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
GPR84 Q9NQS5 1/20 0.38
GSTP1 P09211 1/20 0.38
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
CYP1A2 P05177 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079986 0.97 ESR1 (0.43) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL19076505 0.94 AHR (0.42) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL19080035 0.94 ESR1 (0.45) ESR1ESR2ALOX5CYP1A1HSD17B1
SCHEMBL17931903 0.94 AHR (0.45) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL22062786 0.94 CASP3 (0.41) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL22062821 0.94 AHR (0.45) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL16067752 0.94 CASP3 (0.41) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL20127572 0.94 CYP1A1 (0.41) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL24923190 0.93 ESR1 (0.40) ESR1ESR2ALOX5CYP1A1CYP1B1
SCHEMBL22063115 0.93 AHR (0.41) ESR1ESR2ALOX5CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885ALOX5 1871/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885ALOX5 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.